Effects of renal dysfunction on cardiovascular events in diabetic patients with hypertension: Challenge-DM Study subgroup analysis

Clinical and Experimental Nephrology

Volumn 15, Issue 1, 2011, Pages 64-72

  Umemura, Satoshi ^a   Kawamori, Ryuzo ^b   Matsuoka, Hiroaki ^c   Saito, Yasushi ^d  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Candesartan; Cardiovascular disease; Diabetes mellitus; eGFR; Hypertension; Renal dysfunction

Indexed keywords

CANDESARTAN HEXETIL; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC PATIENT; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAPANESE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MIDDLE AGED; TETRAZOLES; YOUNG ADULT;

EID: 79952190527     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0344-6     Document Type: Article

References (20)

1. AS Levey JA Beto BE Coronado G Eknoyan RN Foley BL Kasiske, et al. 1998 Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease Am J Kidney Dis 32 S112 S119 10.1016/S0272-6386(98)70145-3
2. BF Culleton MG Larson PW Wilson JC Evans PS Parfrey D Levy 1999 Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency Kidney Int 56 2214 2219 1:STN:280:DC%2BD3c%2FmtlWjuw%3D%3D 10.1046/j.1523-1755.1999.00773.x 10594797 (Pubitemid 30004750)
3. LM Ruilope A Salvetti K Jamerson L Hansson I Warnold H Wedel, et al. 2001 Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study J Am Soc Nephrol 12 218 225 1:STN:280:DC%2BD3M7mt1CjsQ%3D%3D 11158211 (Pubitemid 32116363)
4. G Schillaci G Reboldi P Verdecchia 2001 High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension Arch Intern Med 161 886 891 1:STN:280:DC%2BD3M3mtVektA%3D%3D 10.1001/archinte.161.6.886 11268234 (Pubitemid 32225400)
5. JF Mann HC Gerstein J Pogue J Bosch S Yusuf for the HOPE Investigators 2001 Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 629 636 1:CAS:528:DC%2BD3MXjsV2ms7Y%3D 11304102 (Pubitemid 32322240)
6. K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 Suppl 1:S1-S266.
7. MJ Sarnak AS Levey AC Schoolwerth J Coresh B Culleton LL Hamm, et al. 2003 Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, and epidemiology and prevention Circulation 108 2154 2169 10.1161/01.CIR.0000095676.90936.80 14581387 (Pubitemid 37337595)
8. AS Go GM Chertow D Fan CE McCulloch C Hsu 2004 Chronic kidney disease and risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296 1305 1:CAS:528:DC%2BD2cXnvFSgtr8%3D 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
9. T Ninomiya Y Kiyohara M Kubo Y Tanizaki Y Doi K Okubo, et al. 2005 Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama study Kidney Int 68 228 236 10.1111/j.1523-1755.2005. 00397.x 15954912 (Pubitemid 43181380)
10. BF Culleton BR Hemmelgarn 2003 Is chronic kidney disease a cardiovascular disease risk factor? Semin Dial 16 95 100 10.1046/j.1525-139X.2003.16024.x 12641871 (Pubitemid 37356821)
11. MO Kaisar NM Isbel DW Johnson 2008 Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease Rev Recent Clin Trials 3 79 88 1:CAS:528:DC%2BD1cXlslahtb4%3D 10.2174/157488708784223853 18474017
12. LA Stevens J Coresh T Greene AS Levey 2006 Assessing kidney function-measured and estimated glomerular filtration rate N Engl J Med 354 2473 2483 1:CAS:528:DC%2BD28XlsVaiurk%3D 10.1056/NEJMra054415 16760447 (Pubitemid 43855050)
13. E Imai M Horio K Nitta K Yamagata K Iseki S Hara, et al. 2007 Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease Clin Exp Nephrol 11 41 50 10.1007/s10157-006-0453-4 17384997 (Pubitemid 46474965)
14. S Matsuo E Imai M Horio Y Yasuda K Tomita K Nitta, et al. 2009 Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 982 992 1:CAS:528:DC%2BD1MXnslKku7c%3D 10.1053/j.ajkd.2008.12.034 19339088
15. R Kawamori R Fujita H Matsuoka S Umemura Y Saito 2009 Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study Diabetes Res Clin Pract 83 241 248 1:CAS:528:DC%2BD1MXhtVCqu7w%3D 10.1016/j.diabres.2008.11.011 19097664
16. HI Feldman LJ Appel GM Chertow D Cifelli B Cizman J Daugirdas, et al. 2003 The chronic renal insufficiency cohort (CRIC) study: design and methods J Am Soc Nephrol 14 S148 S153 10.1097/01.ASN.0000070149.78399.CE 12819321
17. E Imai S Matsuo H Makino T Watanabe T Akizawa K Nitta, et al. 2008 Chronic kidney disease Japan cohort (CKD-JAC) study: design and methods Hypertens Res 31 1101 1107 10.1291/hypres.31.1101 18716357
18. Anavekar NS, Pfeffer MA. Cardiavascular risk in chronic kidney disease. Kidney Int. 2004;66 Suppl 92: S11-S15.
19. S Balamuthusamy L Srinivasan M Verma S Adigopula N Jalandara S Hathiwala, et al. 2008 Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis Am Heart J 155 791 805 1:CAS:528:DC%2BD1cXlsFCht78%3D 10.1016/j.ahj.2008.01.031 18440325 (Pubitemid 351601744)
20. R Kunz C Friedrich M Wolbers JF Mann 2008 Meta-analysis: effect of monotherapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease Ann Intern Med 148 30 48 17984482 (Pubitemid 351688350)